Lidocaine hydrochloride 50 MG/ML Topical Spray — RxCUI 1545290
RxNorm drug concept · Semantic clinical drug
RxCUI 1545290
Semantic clinical drug · SCD
● Current RxNorm concept 5 FDA products
5 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1545290
Official nameLidocaine hydrochloride 50 MG/ML Topical Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslidocaine hydrochloride 5 % Topical Spray; lidocaine HCl 5 % Topical Spray
FDA products mapped5
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- This patch is used to treat post-herpetic neuralgia — that's the persistent burning or aching nerve pain that sometimes sticks around after a shingles outbreak, even after the rash...
- What is this patch actually for — why did my doctor prescribe it?
- You wear it for up to 12 hours, then take it off for the next 12 hours — think of it as '12 hours on, 12 hours off.' Your prescriber may allow up to 3 patches at a time, but never...
- How long do I wear the patch, and can I wear more than one?
🕸️ Concept Web — How Lidocaine hydrochloride 50 MG/ML Topical Spray Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Lidocaine hydrochloride 50 MG/ML Topical Spray
RxCUI 1545290 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Lidocaine
6387IN -
Lidocaine hydrochloride
142440PIN
-
Lidocaine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lidotral
1723992BN
-
Lidotral
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lidocaine Topical Spray
377328SCDF -
Lidocaine hydrochloride Topical Spray
2645912SCDFP -
Lidocaine Topical Product
1164666SCDG -
Lidocaine hydrochloride Topical Product
2661923SCDGP -
Lidocaine Topical Spray [Lidotral]
2684034SBDF -
Lidocaine hydrochloride Topical Spray [Lidotral]
2684035SBDFP -
Lidotral Topical Product
1723995SBDG -
Topical Spray
346165DF - +1 more in this family
-
Lidocaine Topical Spray
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lidocaine hydrochloride 50 MG/ML
1011092SCDC -
Lidocaine hydrochloride 50 MG/ML Topical Spray [Lidotral]
2684036SBD -
Lidocaine hydrochloride 50 MG/ML [Lidotral]
2684033SBDC
-
Lidocaine hydrochloride 50 MG/ML
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Lidocaine hydrochloride 50 MG/ML
SCDC · 1011092 -
Lidocaine Topical Spray
SCDF · 377328 -
Lidocaine hydrochloride Topical Spray
SCDFP · 2645912 -
Lidocaine Topical Product
SCDG · 1164666 -
Lidocaine hydrochloride Topical Product
SCDGP · 2661923
Brand-Name Concepts
-
Lidocaine hydrochloride 50 MG/ML Topical Spray [Lidotral]
SBD · 2684036 -
Lidocaine hydrochloride 50 MG/ML [Lidotral]
SBDC · 2684033 -
Lidocaine Topical Spray [Lidotral]
SBDF · 2684034 -
Lidocaine hydrochloride Topical Spray [Lidotral]
SBDFP · 2684035 -
Lidotral Topical Product
SBDG · 1723995 -
Lidotral
BN · 1723992
📦 FDA Products & Package NDCs
5 products · 5 package NDCs
5 package NDCs map to RxCUI 1545290 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 59088-0350-03 | 30 mL in 1 BOTTLE, SPRAY (59088-350-03) | Lidotral Five Percent | PureTek Corporation | 2024-06-04 |
| 70171-0400-01 | 1 BOTTLE, SPRAY in 1 CARTON (70171-0400-1) / 28 g in 1 BOTT... | Bravado Labs Numbing | Prodigy Media Inc | 2025-07-27 |
| 71131-0050-04 | 118.29 mL in 1 BOTTLE, SPRAY (71131-050-04) | Uber Numb | UBERScientific, LLC | 2017-11-01 |
| 76348-0980-04 | 118 mL in 1 BOTTLE, SPRAY (76348-980-04) | RECOVERY Numbing | Renu Laboratories, LLC | 2022-08-01 |
| 82617-0102-12 | 60 mL in 1 BOTTLE, SPRAY (82617-102-12) | THE SOLUTION 2.0 | SCALP TECH INC | 2024-01-23 |
Observed labelers:
Prodigy Media Inc (1) ·
PureTek Corporation (1) ·
Renu Laboratories, LLC (1) ·
SCALP TECH INC (1) ·
UBERScientific, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.